Efficacy of homoharringtonine-based induction regimen in acute myeloid leukemia (AML) with double-mutated CCAAT/enhancer-binding protein alpha (CEBPA): A prospective multicenter, single-arm trial
Efficacy of homoharringtonine-based induction regimen in acute myeloid leukemia (AML) with double-mutated CCAAT/enhancer-binding protein alpha (CEBPA): A prospective multicenter, single-arm trial
Fred Hutch Cancer Center to lead $15 million national clinical trial initiative for older adults with acute myeloid leukemia
Uncovering a new vulnerability in acute myeloid leukemia - EurekAlert!
FLAG-based regimen delivers strong outcomes in subtype of acute myeloid leukemia - EurekAlert!
Combination strategies for immunotherapy in acute myeloid leukemia - EurekAlert!
Researchers discover new acute myeloid leukemia “don’t eat me” signal - EurekAlert!